 <h1>Istradefylline Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to istradefylline: oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, istradefylline may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking istradefylline:</p><p>
<i>More common</i>
</p><ul>
<li>Seeing, hearing, or feeling things that are not there</li>
<li>twitching, twisting, uncontrolled repetitive movements of tongue, lips, face, arms, or legs </li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Actions that are out of control</li>
<li>anxiety</li>
<li>attack, assault, force</li>
<li>confusion</li>
<li>confusion as to time, place, or person</li>
<li>delusions of persecution, mistrust, suspiciousness, or combativeness</li>
<li>dry mouth</li>
<li>false beliefs that cannot be changed by facts</li>
<li>hyperventilation</li>
<li>increased sexual urges</li>
<li>irregular heartbeats</li>
<li>irritability</li>
<li>restlessness</li>
<li>shaking</li>
<li>shortness of breath</li>
<li>talking, feeling, and acting with excitement</li>
<li>trouble sleeping</li>
<li>unusual excitement, nervousness, or restlessness</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of istradefylline may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Difficulty having a bowel movement (stool)</li>
<li>nausea</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Decreased appetite</li>
<li>diarrhea</li>
<li>dizziness</li>
<li>rash</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to istradefylline: oral tablet</i></p><h3>General</h3><p>The most commonly reported adverse reactions have included dyskinesia, dizziness, constipation, nausea, hallucinations, and insomnia.<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Across clinical trials, dyskinesia occurred in 15% of patients receiving 20 mg once a day and 17% of patients receiving 40 mg once a day (compared to 8% for placebo); 1% of patients discontinued treatment because of dyskinesia.</p><p><b>Very common</b> (10% or more): Dyskinesia (up to 17%) </p>
<p><b>Common</b> (1% to 10%): Dizziness</p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Constipation, nausea</p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash</p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Decreased appetite, increased blood glucose</p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Blood alkaline phosphatase increased</p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Upper respiratory tract inflammation</p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Blood urea increased</p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Hallucinations, abnormal thinking and behavior, insomnia</p>
<p><b>Rare</b> (less than 0.1%): Impulse control disorder </p>
<p><b>Postmarketing reports</b>: Increased libido</p><p>Across clinical trials, hallucinations occurred in 2% of patients receiving 20 mg once a day and 6% of patients receiving 40 mg once a day (compared to 3% for placebo); 1% of patients discontinued treatment because of hallucinations.  Across clinical trials, abnormal thinking and behavior (paranoid ideation, delusions, confusion, mania, disorientation, aggressive behavior, agitation, or delirium) occurred in 1% of patients receiving 20 mg once a day and 2% of patients receiving 40 mg once a day (compared to 1% for placebo).  Across clinical trials, 1 patient taking 40 mg/day reported an impulse control disorder.  There were no reports in the patients taking 20 mg/day or placebo.</p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Nourianz (istradefylline)." Kyowa Kirin, Inc, Bedminster, NJ. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about istradefylline</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>1 Review</li>
<li>Drug class: miscellaneous antiparkinson agents</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Istradefylline &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Nourianz</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Parkinson's Disease</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to istradefylline: oral tablet</i></p><h3>General</h3><p>The most commonly reported adverse reactions have included dyskinesia, dizziness, constipation, nausea, hallucinations, and insomnia.<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Across clinical trials, dyskinesia occurred in 15% of patients receiving 20 mg once a day and 17% of patients receiving 40 mg once a day (compared to 8% for placebo); 1% of patients discontinued treatment because of dyskinesia.</p><p><b>Very common</b> (10% or more): Dyskinesia (up to 17%) </p><p><b>Common</b> (1% to 10%): Dizziness</p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Constipation, nausea</p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash</p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Decreased appetite, increased blood glucose</p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Blood alkaline phosphatase increased</p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Upper respiratory tract inflammation</p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Blood urea increased</p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Hallucinations, abnormal thinking and behavior, insomnia</p><p><b>Rare</b> (less than 0.1%): Impulse control disorder </p><p><b>Postmarketing reports</b>: Increased libido</p><p>Across clinical trials, hallucinations occurred in 2% of patients receiving 20 mg once a day and 6% of patients receiving 40 mg once a day (compared to 3% for placebo); 1% of patients discontinued treatment because of hallucinations.  Across clinical trials, abnormal thinking and behavior (paranoid ideation, delusions, confusion, mania, disorientation, aggressive behavior, agitation, or delirium) occurred in 1% of patients receiving 20 mg once a day and 2% of patients receiving 40 mg once a day (compared to 1% for placebo).  Across clinical trials, 1 patient taking 40 mg/day reported an impulse control disorder.  There were no reports in the patients taking 20 mg/day or placebo.</p><p id="ref_1">1. "Product Information. Nourianz (istradefylline)." Kyowa Kirin, Inc, Bedminster, NJ. </p><h2>More about istradefylline</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>1 Review</li>
<li>Drug class: miscellaneous antiparkinson agents</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Istradefylline &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Parkinson's Disease</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>